Douglas Carl Fisher
CIK 1572355 · President · last filed 2024-02-16
Douglas Carl Fisher is a President who has filed 19 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for PBAXW, was dated Feb 16, 2024. Current disclosed insider exposure totals $107.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PRPO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WOODSIDE, CA 94062
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | President | 43,300 | $0.05 | $2.2K | $0 | 1 | 2024-02-16 |
| PRPO | Director | 5,572 | $19.35 | $107.8K | $0 | 11 | 2023-10-31 |
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | President | 10,000 | $10.37 | $103.7K | $0 | 1 | 2021-10-12 |
| Vyome Holdings, Inc (OBLN) Delisted | Director | 26,042 | $9.15 | $238.3K | $0 | 6 | 2020-09-18 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-16 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Mixed | +43,300 | $0 | EDGAR |
| 2023-10-31 | PRPO | Grant (A) | +5,174 | $0 | EDGAR |
| 2023-09-14 | PRPO | Grant (A) | +7,954 | $0 | EDGAR |
| 2023-01-10 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2022-01-13 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2021-10-12 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | Other (J) | +10,000 | $0 | EDGAR |
| 2021-08-05 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2021-01-05 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2020-09-18 | Vyome Holdings, Inc (OBLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-06 | PRPO | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.